Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Once reconstituted, store the vial under refrigeration at 4 C (39 F)
Horowitz M, Nauck MA
Imvax Founded: 2015 Technology / disease area: Personalized immunotherapy for solid tumors, with a focus on glioblastoma Lead candidate: IGV-001 Imvax works on personalized immunotherapies for solid tumors, anchored by its proprietary Goldspire platform
Following the consultation, our team in Lake Charles focuses on verifying insurance coverage and handling prior authorization
Contacts Bailey Wray anthonyBarnum Public Relations [email protected] 318.470.5403 This release was updated in October 2024 to reflect the latest regulatory news.
Support staff were polite but did not appear to have read the full context of our questions
US$ 23.15
US$ 24.20
US$ 27.87
US$ 21.33
US$ 20.38
